Lentiviral-transduced CD34+ hematopoietic stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lentiviral-transduced CD34+ hematopoietic stem cells, covering 2024-10-23 to 2024-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients. [Phase 1]